Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Endocr Relat Cancer. 2009 May 15;16(3):835–844. doi: 10.1677/ERC-09-0054

Figure 3.

Figure 3

Antiproliferative activity of MCDF. Inhibition of ER-negative breast cancer cell growth. ER-negative breast cancer cell lines were treated with DMSO or different concentrations of MCDF for six days and cells were counted as described in the Materials and Methods. Results are expressed as means ± SE for 3 replicate determinations for each treatment group and significant (p < 0.05) of cell proliferation is indicated (*).